TY - JOUR
T1 - Systematic Review and meta-analysis
T2 - International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3
AU - Cifuentes-González, Carlos
AU - Le Tong, Yong
AU - Rojas-Carabali, William
AU - Mejía-Salgado, Germán
AU - Putera, Ikhwanuliman
AU - Song, Xin Ying Rachel
AU - Walter, Cheong Fu Yuan
AU - Shengjuan, Zhang
AU - Chan, Reo
AU - Mobasserian, Azadeh
AU - Nora, Rina La Distia
AU - Biswas, Jyotirmay
AU - Gangaputra, Sapna
AU - Pulido, Jose S.
AU - Kempen, John H.
AU - Nguyen, Quan Dong
AU - de la Torre, Alejandra
AU - Gupta, Vishali
AU - Rosenbaum, James T.
AU - Agrawal, Rupesh
N1 - Publisher Copyright:
© 2025 Elsevier Inc.
PY - 2025
Y1 - 2025
N2 - We investigate the clinical characteristics and complications of retinal vasculitis (RV), categorizing cases into Secondary RV (associated with systemic disease), Syndromic RV (linked to ocular syndromes without systemic disease), Idiopathic RV (without systemic disease or ocular syndrome diagnoses), and Multiple Etiology RV (cohorts of retinal vasculitis with more than one subcategories of the above). A systematic search was conducted on June 14, 2023, across PubMed, Embase, Cochrane (Ovid), VHL, and ProQuest databases, following PRISMA guidelines (PROSPERO registration: CRD42023489232). Out of 5533 screened articles, 97 studies involving 7619 patients with RV met the eligibility criteria. Bilateral involvement (64 %) and reduced vision (52 %) were common across all RV categories, with Idiopathic RV showing the highest rates of bilateral involvement (80 %) and vision loss (79 %). Syndromic RV was characterized by retinal ischemia (76 %) and vitreous hemorrhage (46 %), while Secondary RV exhibited higher incidences of cystoid macular edema (32 %) and neovascular glaucoma (24 %). Geographic variations were evident in Multiple Etiology RV, with inflammation in more than 1 intraocular structure more prevalent in Asia (64 %) than in Europe (29 %). These findings highlight the heterogeneity in RV presentation and complications, illustrating the need for standardized diagnostic criteria and improved clinical reporting to enable better classification, treatment strategies, and patient outcomes.
AB - We investigate the clinical characteristics and complications of retinal vasculitis (RV), categorizing cases into Secondary RV (associated with systemic disease), Syndromic RV (linked to ocular syndromes without systemic disease), Idiopathic RV (without systemic disease or ocular syndrome diagnoses), and Multiple Etiology RV (cohorts of retinal vasculitis with more than one subcategories of the above). A systematic search was conducted on June 14, 2023, across PubMed, Embase, Cochrane (Ovid), VHL, and ProQuest databases, following PRISMA guidelines (PROSPERO registration: CRD42023489232). Out of 5533 screened articles, 97 studies involving 7619 patients with RV met the eligibility criteria. Bilateral involvement (64 %) and reduced vision (52 %) were common across all RV categories, with Idiopathic RV showing the highest rates of bilateral involvement (80 %) and vision loss (79 %). Syndromic RV was characterized by retinal ischemia (76 %) and vitreous hemorrhage (46 %), while Secondary RV exhibited higher incidences of cystoid macular edema (32 %) and neovascular glaucoma (24 %). Geographic variations were evident in Multiple Etiology RV, with inflammation in more than 1 intraocular structure more prevalent in Asia (64 %) than in Europe (29 %). These findings highlight the heterogeneity in RV presentation and complications, illustrating the need for standardized diagnostic criteria and improved clinical reporting to enable better classification, treatment strategies, and patient outcomes.
UR - http://www.scopus.com/inward/record.url?scp=105005506661&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105005506661&partnerID=8YFLogxK
U2 - 10.1016/j.survophthal.2025.04.001
DO - 10.1016/j.survophthal.2025.04.001
M3 - Review article
C2 - 40320076
AN - SCOPUS:105005506661
SN - 0039-6257
JO - Survey of Ophthalmology
JF - Survey of Ophthalmology
ER -